Aarti Industries Ltd Q3 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/uokotu2el1pt30d6pkew3iad.pdf

Key Takeaways


Volume Recovery & the Quarter’s Drivers

Suyog Kotecha: "Having indigenous technology developed by our own in-house R&D where we can optimize the cost sheets for each of these products gives us that ability and license and one of the reasons why we have been able to increase volumes and I would say, maintain our market share over the course of last 2 years despite significant pricing pressure from China"

China Anti-Involution & the Pricing Inflection

Suyog Kotecha: "The only impact where it was immediately visible for us was in NCB chain, right, where pricing went up within a span of a few days by almost 7%-10%."

MMA: Global Leadership, Integration & the Tariff Advantage

Suyog Kotecha: "I think from volumes sold in the market, we can confidently say that we are the global leader, right. And we intend to remain a global leader as far as this product is concerned."

Tariffs, Trade Deals & the U.S. Reset

Suyog Kotecha: "I think if we are competing against Chinese players, trying to dump volumes in India, I am sure we can handle European volumes."

Zone 4, JVs & the Advanced Materials Pivot


Growth Partnerships & the FY28 Ambition

Suyog Kotecha: "There are bumps here and there. But I think by and large, if we are able to implement all of it and if there is no major external event, then we remain committed to achieving our midterm targets."

Guidance & Commitments

CommitmentSpecificsTimeline
MMA capacity expansionScale from 290+ KT to ~360 KTAvailable by end of Q4 FY26
DCB debottleneckingCapacity increase from 120 to 140 KTPAApproved; timeline not specified
Zone 4 commissioning (first units)Calcium chloride and multipurpose plantsWithin Q4 FY26
Zone 4 commissioning (remaining blocks)MPP, Chloro toluene and downstream process blocksPhased through first 3 quarters of FY27
Superform JV commissioningAgrochemical, paints and coatings applicationsQ1 FY27
RESL JV commissioningFirst manufacturing unitH1 FY27
FY27 capexSignificantly lower than FY26 (~₹1,100 crore)FY27
MMA portfolio shareSettle at 30–40% of portfolio2–3 year outlook
FY28 EBITDA targetMaintained, barring major external eventsFY28
Growth partnership closuresNarrow down and close some long-term strategic partnershipsNear future, aided by recent trade deals

Key Metrics

MetricQ3 FY26
Revenue₹2,492 cr, +11% QoQ driven by volume growth across MMA, NT, DCB
EBITDA₹323 cr, +11% QoQ
EBITDA margin13.0% (per an analyst's math)
Profit After Tax₹133 cr, +25% QoQ
Exceptional expense (new labour code)₹15 cr, one-time impact; further provisions possible pending government notification
Exports share65% of total revenues, highest ever in percentage and absolute terms
Operating cash flow (9M FY26)₹500–600 cr
CAPEX guidance FY26₹1,100 cr, revised up from ₹1,000 cr due to incremental MMA, PEDA, DCB projects
Zone 4 total CAPEX₹1,600–1,800 cr, bulk deployed by year-end; ₹300–400 cr remaining for FY27
MMA capacity~290+ KT scaling to ~360 KT by Q4 FY26
DCB capacity120 KTPA debottlenecking to 140 KTPA
MMA share of US exports50–60% of total exports to US
PDCB share of US exports15–25% of total exports to US
NCB chain pricing increase7–10% within days following China VAT subsidy removal
Agrochemicals revenue share17–18% on 9M/full-year basis; 12% in Q3 due to bulk shipment timing